Operator: Good morning. Welcome to Quoin Pharmaceuticals, Ltd. Second Quarter Fiscal Results and Business Update Conference Call. All participants will be in a listen-only mode.
Krystal Biotech Announces Second Quarter 2023 Financial Results and Operational Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
• VYJUVEK™ approved in the U.S. as the first and only topical redosable gene therapy for the treatment of dystrophic epidermolysis bullosa • 121 Patient Start Forms in the first six weeks of.
Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was assessed to be fully clear by Investigator at QRX003.
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.